# Editorial: Exploring evidence for neurorehabilitation advancements

**Authors:** Hideki Nakano, Akiyoshi Matsugi, Tomotaka Ito, Kosuke Oku, Masahiro Sakita

PMC · DOI: 10.3389/fnhum.2025.1636154 · 2025-06-18

## Full-text entities

- **Diseases:** sensory impairment (MESH:D012678), motor impairment (MESH:D000068079), pain (MESH:D010146), post-stroke hemiplegia (MESH:D006429), disorders of consciousness (MESH:D003244), acute stroke (MESH:D020521), neurological diseases (MESH:D020271), dysphagia (MESH:D003680), peripheral neuropathy (MESH:D010523), long COVID (MESH:D000094024), paralysis (MESH:D010243), disorders (MESH:D009358), infectious diseases (MESH:D003141), aneurysmal subarachnoid hemorrhage (MESH:D013345), cancer (MESH:D009369), malnutrition (MESH:D044342), aphasia (MESH:D001037), COVID-19 sequelae (MESH:D000086382), psychiatric (MESH:D001523), fatigue (MESH:D005221), cerebellar ataxia (MESH:D002524), developmental and neurological disorders (MESH:D009422), cognitive impairment (MESH:D003072), spinal cord injury (MESH:D013119), paresis (MESH:D010291), nervous system injuries (MESH:D020196), MCI (MESH:D060825)
- **Chemicals:** Vojta (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12213755